Combating COVID-19 with Cell-Free Expression

Scientists rely on synthetic biology and cell-free expression systems for developing novel approaches to combat the pandemic.

Written byThe Scientist Creative Services Team
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Imagine the ability to rewire, reshape, and use parts of a living system to build something new. It is not science fiction, nor is it Frankenstein’s monster. It is synthetic biology, a relatively nascent field that is making a profound impact on society and healthcare. As the world continues to grapple with the ongoing effects of the COVID-19 pandemic, researchers are turning to synthetic biology, and in particular, to cell-free expression systems to develop new rapid diagnostic tools, vaccines, and treatments.

“It’s a way to program information. We all do that every day in our cell phones; we program information in zeros and ones. Synthetic biology takes that to a totally new dimension. Rather than just being able to control information, I now get to control information that builds atoms,” said Michael Jewett, a professor of chemical and biological engineering at Northwestern University.

Synthetic biologists such as Jewett combine engineering ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies